SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cambridge Antibody Technology Group

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jongmans who started this subject3/29/2001 9:26:56 AM
From: nigel bates  Read Replies (2) of 625
 
LONDON, March 29 (Reuters) - British needleless syringe firm Weston Medical (LSE: WMG.L - news) Group Plc said on Thursday it had entered into a multi-product evaluation and development agreement with Cambridge Antibody Technology Group Plc .
"Under the terms of this agreement, payments may be made to Weston Medical on reaching specified evaluation milestones," Weston said in a statement.
Weston, which lost a quarter of its value last month after it announced it had ended a development deal with Johnson & Johnson , announced an operating loss before exceptional items for 2000 of 6.9 million pounds, compared to a loss of 3.0 million pounds in the previous year....
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext